Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2 Interventional

A Phase II Study of AS1411 in Renal Cell Carcinoma

ClinicalTrials.gov ID: NCT00740441

Public ClinicalTrials.gov record NCT00740441. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 3:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Open Label, Single Arm Study of AS1411 in Patients With Metastatic Renal Cell Carcinoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The aim of this study is to evaluate the efficacy of AS1411 in patients with Metastatic Renal Cell Carcinoma

Study identification

NCT ID
NCT00740441
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Antisoma Research
Industry
Enrollment
30 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2008 (Type not available)
Primary completion
Sep 2009 (Estimated)
Completion
Mar 2010 (Estimated)
Last update posted
Sep 25, 2009

2008 – 2010

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
7
Facility City State ZIP Site status
City of Hope Duarte California 91010 —
University of California, Davis Cancer Center Sacramento California 95817 —
University of California San Francisco San Francisco California 94143 —
St Francis Hospital Beech Grove Indiana 46107 —
James Graham Brown Cancer Center, University of Louisville Louisville Kentucky 40202 —
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute Boston Massachusetts 02115 —
Medical University of South Carolina Charleston South Carolina 29403 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00740441, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 25, 2009 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00740441 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →